The U.S. Food and Drug Administration (FDA) on Thursday approved the medication Exxua to treat major depressive disorder – a significant step after a decades-long battle for approval. Exxua is unique for its ability to target the serotonin 1A receptor, which is a regulator of mood and emotion. In doing so, it avoids undesirable side… Source
Related posts:
Volusia Deputy Suspended after 4-vehicle Crash in Edgewater
Alphabet Loses Over $110 Billion Market Cap After AI ChatBot ‘Glitch’
Taiwan Death Reports After Injection Outnumber COVID Deaths, Myocarditis Cover Up & Exposing Misinfo
Hollywood Celebrities Freak After SCOTUS Delivers Second Amendment Victory: 'Truly Disgraceful Rulin...
Israel prepares to receive Jewish immigrants after Putin's 'partial mobilisation' decision
Will Conservatives Succeed or Fail After April Elections?